Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

190.55
+3.441.84%
Post-market: 189.80-0.7500-0.39%19:59 EDT
Volume:4.34M
Turnover:823.23M
Market Cap:336.59B
PE:81.43
High:190.80
Open:187.05
Low:186.77
Close:187.11
Loading ...

Health Rounds: Researchers identify best drugs for severe COVID

Reuters
·
23 May

AbbVie Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
22 May

Ameriprise Financial Initiates AbbVie at Buy

MT Newswires Live
·
20 May

Regenxbio Signs Royalty Deal Worth Up to $250 Million With Healthcare Royalty

MT Newswires Live
·
20 May

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
16 May

AbbVie Inc. Stock Slips 5.6%, Underperforms Competitors

Dow Jones
·
15 May

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

Reuters
·
15 May

BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment

Reuters
·
15 May

AbbVie Says US FDA Approved Emrelis for Lung Cancer Indication

MT Newswires Live
·
15 May

US FDA approves AbbVie's drug for a type of lung cancer

Reuters
·
15 May

AbbVie Announces FDA Accelerated Approval of EMRELIS™ for Advanced Non-Small Cell Lung Cancer Treatment

Reuters
·
15 May

Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck. -- Barrons.com

Dow Jones
·
14 May

AbbVie, ADARx Pharmaceuticals Launch Collaboration Focused on siRNA Therapies for Multiple Diseases

MT Newswires Live
·
14 May

AbbVie Inc. Partners with ADARx Pharmaceuticals to Advance Next-Generation siRNA Therapies Across Multiple Therapeutic Areas

Reuters
·
14 May

AbbVie Cut to Neutral From Buy by Citigroup

Dow Jones
·
14 May

BUZZ-Citi downgrades AbbVie on US policy risks, pipeline concerns

Reuters
·
14 May

Citigroup Downgrades AbbVie to Neutral From Buy, Adjusts Price Target to $205 From $210

MT Newswires Live
·
14 May

AbbVie Inc. Files Initial Statement of Beneficial Ownership for Director Thomas J. Falk

Reuters
·
14 May

Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump's Executive Order. -- Barrons.com

Dow Jones
·
13 May

BRIEF-Abbvie Inc - Expands Board To 15 Directors, Appoints Thomas J. Falk - SEC Filing

Reuters
·
13 May